{"title":"血管性帕金森病发展的双重打击理论","authors":"H. Manosalva","doi":"10.33805/2641-8991.120","DOIUrl":null,"url":null,"abstract":"Introduction: Identify the non-decoded network in Vascular Parkinsonism (VasP). Objective: To determine what pattern of stroke lesions is responsible for VasP, as compared to those patients who had stroke, gait and balance problems, but absence of a hypokinetic rigid syndrome also called Vascular Pseudo Parkinsonism-V PSeuP. Materials and Methods: Design: prospective cohort study. Participants were consecutively screened for parkinsonian symptoms during a year as according to our previous study. Validated questionnaire (Tanner Questionnaire-TQ) was used, and a new scale operationalizing the criteria for VasP (FMAS score). All participants in the original study had a clinical exam to identify if presence of a hypokinetic rigid syndrome. Lesion patterns were analyzed. Setting: tertiary care stroke prevention clinic at the University of Alberta Hospital. Participants: Eligible participants attained a score of ≥ 4 on the TQ, high risk for parkinsonism. Four groups were considered: V PseuP, VasP (onset of parkinsonism within a year of the stroke -FMAS score of 4), Pseudo Vascular Parkinsonism-PseuVP (hypokinetic rigid syndrome not related to stroke), and Pseudo Vascular Pseudo Parkinsonism-PseuV PseuP (no stroke and no extrapyramidal syndrome), but with gait and balance problems. Baseline demographic information and clinical characteristics were recorded including vascular risk factors, and stroke subtype. All participants had a Holter, CT head and/or brain MRI, and CTA. Medications that produce drug-induced-parkinsonism were recorded for every participant. The primary outcome was to find the pattern of anatomical lesions particularly involved in the VasP subgroup considering the Basal Ganglia Motor Output Circuit-BGMO, the Thalamo Cortical Drive Loop-TCD and connections to frontal cortex. Results: 240 consecutive participants were screened during 12 months. We found 46 patients with potential Parkinsonism (TQ>4). VPseuP was found in 25/46 (54%), VasP in 8/46 (17%), PseuVP in 7/46 (15%), and PseuV PseuP in 6/46 (14%). VasP were older (p<0.0007) and had a higher risk for cardio embolism due to atrial fibrillation (p=0.02, odd ratio 6.6 CI 95% (1.2 – 35.2)). Neuro images showed that only the pattern involving the BGMO and frontal cortex was significantly associated to the group of VasP (X2 Fisher exact test p<0.0005 Odds ratio 32 CI 95% (9.6-108)); whereas the pattern TCD was not significantly different between the groups (X2 Fisher exact test p=0.828 Odds ratio 1.2 CI 95% (0.5-2.8)). Discussion and Conclusion: A two strategic location hit within the BGMO circuit and frontal cortex is required, so a phenotype of VasP may occur.","PeriodicalId":315780,"journal":{"name":"Neurophysiology and Rehabilitation","volume":"68 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Double Hit Theory for the Development of Vascular Parkinsonism\",\"authors\":\"H. Manosalva\",\"doi\":\"10.33805/2641-8991.120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Identify the non-decoded network in Vascular Parkinsonism (VasP). Objective: To determine what pattern of stroke lesions is responsible for VasP, as compared to those patients who had stroke, gait and balance problems, but absence of a hypokinetic rigid syndrome also called Vascular Pseudo Parkinsonism-V PSeuP. Materials and Methods: Design: prospective cohort study. Participants were consecutively screened for parkinsonian symptoms during a year as according to our previous study. Validated questionnaire (Tanner Questionnaire-TQ) was used, and a new scale operationalizing the criteria for VasP (FMAS score). All participants in the original study had a clinical exam to identify if presence of a hypokinetic rigid syndrome. Lesion patterns were analyzed. Setting: tertiary care stroke prevention clinic at the University of Alberta Hospital. Participants: Eligible participants attained a score of ≥ 4 on the TQ, high risk for parkinsonism. Four groups were considered: V PseuP, VasP (onset of parkinsonism within a year of the stroke -FMAS score of 4), Pseudo Vascular Parkinsonism-PseuVP (hypokinetic rigid syndrome not related to stroke), and Pseudo Vascular Pseudo Parkinsonism-PseuV PseuP (no stroke and no extrapyramidal syndrome), but with gait and balance problems. Baseline demographic information and clinical characteristics were recorded including vascular risk factors, and stroke subtype. All participants had a Holter, CT head and/or brain MRI, and CTA. Medications that produce drug-induced-parkinsonism were recorded for every participant. The primary outcome was to find the pattern of anatomical lesions particularly involved in the VasP subgroup considering the Basal Ganglia Motor Output Circuit-BGMO, the Thalamo Cortical Drive Loop-TCD and connections to frontal cortex. Results: 240 consecutive participants were screened during 12 months. We found 46 patients with potential Parkinsonism (TQ>4). VPseuP was found in 25/46 (54%), VasP in 8/46 (17%), PseuVP in 7/46 (15%), and PseuV PseuP in 6/46 (14%). VasP were older (p<0.0007) and had a higher risk for cardio embolism due to atrial fibrillation (p=0.02, odd ratio 6.6 CI 95% (1.2 – 35.2)). Neuro images showed that only the pattern involving the BGMO and frontal cortex was significantly associated to the group of VasP (X2 Fisher exact test p<0.0005 Odds ratio 32 CI 95% (9.6-108)); whereas the pattern TCD was not significantly different between the groups (X2 Fisher exact test p=0.828 Odds ratio 1.2 CI 95% (0.5-2.8)). Discussion and Conclusion: A two strategic location hit within the BGMO circuit and frontal cortex is required, so a phenotype of VasP may occur.\",\"PeriodicalId\":315780,\"journal\":{\"name\":\"Neurophysiology and Rehabilitation\",\"volume\":\"68 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurophysiology and Rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33805/2641-8991.120\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurophysiology and Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33805/2641-8991.120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
介绍:确定血管性帕金森病(VasP)的非解码网络。目的:与那些有中风、步态和平衡问题,但没有低运动僵硬综合征(也称为血管性假性帕金森病- v pup)的患者相比,确定卒中病变的哪种模式负责VasP。材料和方法:设计:前瞻性队列研究。根据我们之前的研究,参与者在一年内连续筛查帕金森症状。使用了经过验证的问卷(Tanner questionnaire - tq),并使用了一个新的量表来操作VasP (FMAS评分)的标准。原始研究的所有参与者都进行了临床检查,以确定是否存在低运动僵硬综合征。分析病变模式。环境:阿尔伯塔大学医院三级护理中风预防诊所。参与者:符合条件的参与者TQ得分≥4分,帕金森高风险。我们考虑了四组:V型伪帕金森病、VasP(中风后一年内出现的帕金森病-FMAS评分为4分)、伪血管性帕金森病-伪帕金森病(与中风无关的低运动僵硬综合征)和伪血管性伪帕金森病-伪帕金森病(无中风和无椎体外系综合征),但有步态和平衡问题。记录基线人口统计信息和临床特征,包括血管危险因素和卒中亚型。所有参与者都进行了动态心电图、头部CT和/或脑部MRI以及CTA检查。每位参与者都记录了产生药物性帕金森症的药物。主要结果是发现解剖损伤的模式,特别是涉及VasP亚群的基底神经节运动输出回路- bgmo,丘脑皮质驱动回路- tcd和与额叶皮质的连接。结果:在12个月内连续筛选了240名参与者。我们发现46例潜在帕金森病(TQ>4)。VPseuP见于25/46 (54%),VasP见于8/46 (17%),pseudop见于7/46 (15%),pseudop见于6/46(14%)。VasP患者年龄较大(p<0.0007),心房颤动引起心脏栓塞的风险较高(p=0.02,奇比6.6 CI 95%(1.2 - 35.2))。神经影像学显示,只有BGMO和额叶皮质的模式与VasP组有显著相关性(X2 Fisher精确检验p<0.0005优势比32 CI 95% (9.6-108));两组间TCD模式差异无统计学意义(X2 Fisher精确检验p=0.828)。优势比1.2 CI 95%(0.5-2.8)。讨论与结论:在BGMO回路和额叶皮层内需要两个战略位置的打击,因此可能会出现VasP的表型。
Double Hit Theory for the Development of Vascular Parkinsonism
Introduction: Identify the non-decoded network in Vascular Parkinsonism (VasP). Objective: To determine what pattern of stroke lesions is responsible for VasP, as compared to those patients who had stroke, gait and balance problems, but absence of a hypokinetic rigid syndrome also called Vascular Pseudo Parkinsonism-V PSeuP. Materials and Methods: Design: prospective cohort study. Participants were consecutively screened for parkinsonian symptoms during a year as according to our previous study. Validated questionnaire (Tanner Questionnaire-TQ) was used, and a new scale operationalizing the criteria for VasP (FMAS score). All participants in the original study had a clinical exam to identify if presence of a hypokinetic rigid syndrome. Lesion patterns were analyzed. Setting: tertiary care stroke prevention clinic at the University of Alberta Hospital. Participants: Eligible participants attained a score of ≥ 4 on the TQ, high risk for parkinsonism. Four groups were considered: V PseuP, VasP (onset of parkinsonism within a year of the stroke -FMAS score of 4), Pseudo Vascular Parkinsonism-PseuVP (hypokinetic rigid syndrome not related to stroke), and Pseudo Vascular Pseudo Parkinsonism-PseuV PseuP (no stroke and no extrapyramidal syndrome), but with gait and balance problems. Baseline demographic information and clinical characteristics were recorded including vascular risk factors, and stroke subtype. All participants had a Holter, CT head and/or brain MRI, and CTA. Medications that produce drug-induced-parkinsonism were recorded for every participant. The primary outcome was to find the pattern of anatomical lesions particularly involved in the VasP subgroup considering the Basal Ganglia Motor Output Circuit-BGMO, the Thalamo Cortical Drive Loop-TCD and connections to frontal cortex. Results: 240 consecutive participants were screened during 12 months. We found 46 patients with potential Parkinsonism (TQ>4). VPseuP was found in 25/46 (54%), VasP in 8/46 (17%), PseuVP in 7/46 (15%), and PseuV PseuP in 6/46 (14%). VasP were older (p<0.0007) and had a higher risk for cardio embolism due to atrial fibrillation (p=0.02, odd ratio 6.6 CI 95% (1.2 – 35.2)). Neuro images showed that only the pattern involving the BGMO and frontal cortex was significantly associated to the group of VasP (X2 Fisher exact test p<0.0005 Odds ratio 32 CI 95% (9.6-108)); whereas the pattern TCD was not significantly different between the groups (X2 Fisher exact test p=0.828 Odds ratio 1.2 CI 95% (0.5-2.8)). Discussion and Conclusion: A two strategic location hit within the BGMO circuit and frontal cortex is required, so a phenotype of VasP may occur.